Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Saifee Mullamitha"'
Autor:
Reem D. Mahmood, Danielle Shaw, Tine Descamps, Cong Zhou, Robert D. Morgan, Saifee Mullamitha, Mark Saunders, Nerissa Mescallado, Alison Backen, Karen Morris, Ross A. Little, Susan Cheung, Yvonne Watson, James P. B. O’Connor, Alan Jackson, Geoff J. M. Parker, Caroline Dive, Gordon C. Jayson
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-8 (2021)
Abstract Background Patients with metastatic colorectal cancer are treated with cytotoxic chemotherapy supplemented by molecularly targeted therapies. There is a critical need to define biomarkers that can optimise the use of these therapies to maxim
Externí odkaz:
https://doaj.org/article/357e10ddf5c4403488351151c9365ef5
Autor:
Timothy Iveson, Angela M. Carter, Kai-Keen Shiu, Clare Spooner, Daniel Stevens, Saifee Mullamitha
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-8 (2020)
Abstract Background The standard first- and second- line chemotherapy backbone regimens for metastatic colorectal cancer (mCRC) are 5-fluorouracil (5-FU)/capecitabine-based with addition of irinotecan or oxaliplatin. Until recently, evidence for opti
Externí odkaz:
https://doaj.org/article/229d9bcaf8e94a7ca6e073aab8cd592e
Autor:
Gordon C. Jayson, Cong Zhou, Alison Backen, Laura Horsley, Kalena Marti-Marti, Danielle Shaw, Nerissa Mescallado, Andrew Clamp, Mark P. Saunders, Juan W. Valle, Saifee Mullamitha, Mike Braun, Jurjees Hasan, Delyth McEntee, Kathryn Simpson, Ross A. Little, Yvonne Watson, Susan Cheung, Caleb Roberts, Linda Ashcroft, Prakash Manoharan, Stefan J. Scherer, Olivia del Puerto, Alan Jackson, James P. B. O’Connor, Geoff J. M. Parker, Caroline Dive
Publikováno v:
Nature Communications, Vol 9, Iss 1, Pp 1-14 (2018)
Identification of response biomarkers is a key step towards the development of personalised care. Here, Jayson et al. identify plasma Tie2 as a biomarker for the response of the tumor vasculature to anti-angiogenics in patients with metastatic colore
Externí odkaz:
https://doaj.org/article/51bffec067d642f8a6e2d9a8af7b2752
Autor:
Mohammed Alani, Saifee Mullamitha, Nooreen Alam, Konstantinos Kamposioras, Michael Braun, Jurjees Hasan, Joanne Collins, Lauren Bayles, Jennifer King, Mark N. K. Saunders, Kalena Marti, Joseph B. Williams, Spencer Finch, Sophina Mahmood, Jorge Barriuso, Kok Haw Jonathan Lim
Publikováno v:
Clinical Colorectal Cancer
Background Since the beginning of the COVID-19 pandemic, multiple changes to the provision of cancer care have been introduced to maximise patient safety and protect staff. We aimed to identify factors influencing clinicians’ decision on treatment
Autor:
Kok Haw Jonathan Lim, Panagiotis Ntellas, Daniel Anderson, Lilly Simpson, Michael Braun, Marios Adamou, Jorge Barriuso, Katerina Dadouli, Jacqueline Connell, Joseph Williams, Theodora Germetaki, Deirdre Lehwald, Niall Fitzpatrick, Mark Cutting, Danielle McCool, Jurjees Hasan, Saifee Mullamitha, Kalena Marti, Mark Saunders, Konstantinos Kamposioras
Publikováno v:
Cancers
Volume 15
Issue 4
Pages: 1226
Volume 15
Issue 4
Pages: 1226
The COVID-19 pandemic has resulted in unprecedented changes to the lives of patients with cancer. To evaluate the impact of the COVID-19 pandemic on the mental health and well-being of patients with colorectal cancer, we conducted a prospective longi
Autor:
Jonathan I. Epstein, Saifee Mullamitha, Fergus Reid, Aali J. Sheen, Michael Braun, Mohammud Kurrimboccus, Jurjees Hassan, Kamran Siddiqui, Thomas Satyadas, Arif Khan, Santhalingam Jegatheeswaran, James Mason, Derek A. O'Reilly, Raj Rajashankar, Rahul Deshpand, Rishi Sethi, Minas Baltatzis, Anthony K.C. Chan, Raymond Mcmahon, Saurabh Jamdar, Nicola de Liguori Carino, James O. Hill, Marius Paraoan, Gregory C. Wilson, Christopher Smart, Ajith K. Siriwardena, Nooreen Alam, David J. Smith, Ramesh Aswatha
Publikováno v:
Annals of Surgical Oncology. 29:1939-1951
BACKGROUND Approximately one-fifth of patients with colorectal cancer present with hepatic metastases. There are limited prospective data on the outcomes of synchronous combined liver and bowel surgery and liver-first or bowel-first routes where cont
Autor:
Kai-Keen Shiu, Clare Spooner, Saifee Mullamitha, Daniel Stevens, Angela M. Carter, Timothy Iveson
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-8 (2020)
BMC Cancer
BMC Cancer
Background The standard first- and second- line chemotherapy backbone regimens for metastatic colorectal cancer (mCRC) are 5-fluorouracil (5-FU)/capecitabine-based with addition of irinotecan or oxaliplatin. Until recently, evidence for optimal seque
Autor:
Nadina Tinsley, Raghavendar Nagaraju, Sarah O'Dwyer, Michael Braun, Saifee Mullamitha, Konstantinos Kamposioras, Omer Aziz, Jorge Barriuso
Publikováno v:
Journal of Clinical Oncology. 41:39-39
39 Background: The role of heated intraperitoneal chemotherapy (HIPEC) in colorectal cancer peritoneal metastases (CRPM) is confounded by cytoreductive surgery (CRS) or receipt of peri-operative systemic anticancer therapy (SACT). Following Prodige-7
Autor:
Jacqueline Connell, Konstantinos Kamposioras, Jorge Barriuso, Michael Braun, Mark P Saunders, Daniel M. Anderson, Jurjees Hasan, Mark Cutting, Lilly Simpson, Kalena Marti, Danielle McCool, Saifee Mullamitha, Victoria Lavin, Kok Haw Jonathan Lim
Publikováno v:
Clinical Colorectal Cancer
Kamposioras, K, Saunders, M, Lim, K H J, Marti, K, Anderson, D, Cutting, M, McCool, D, Connell, J, Thompson, L, Hasan, J, Braun, M, Lavin, V, Mullamitha, S & Barriuso, J 2020, ' The impact of changes in service delivery in patients with colorectal cancer during the initial phase of the COVID-19 pandemic ', Clinical Colorectal Cancer, vol. 0, 0, pp. 0 . https://doi.org/10.1016/j.clcc.2020.11.006
Kamposioras, K, Saunders, M, Lim, K H J, Marti, K, Anderson, D, Cutting, M, McCool, D, Connell, J, Thompson, L, Hasan, J, Braun, M, Lavin, V, Mullamitha, S & Barriuso, J 2020, ' The impact of changes in service delivery in patients with colorectal cancer during the initial phase of the COVID-19 pandemic ', Clinical Colorectal Cancer, vol. 0, 0, pp. 0 . https://doi.org/10.1016/j.clcc.2020.11.006
Background The COVID-19 pandemic has imposed significant changes in cancer service delivery resulting in increased anxiety and distress in both patients and clinicians. We aimed to investigate how these changes have been perceived by patients diagnos
Autor:
Sarah T O'Dwyer, Omer Aziz, Mark P Saunders, Saifee Mullamitha, Jorge Barriuso, D. S. Bhullar
Publikováno v:
EBioMedicine
Bhullar, D S, Barriuso, J, Mullamitha, S, Saunders, M P, O'Dwyer, S & Aziz, O 2019, ' Biomarker concordance between primary colorectal cancer and its metastases ', EBioMedicine . https://doi.org/10.1016/j.ebiom.2019.01.050
Bhullar, D S, Barriuso, J, Mullamitha, S, Saunders, M P, O'Dwyer, S & Aziz, O 2019, ' Biomarker concordance between primary colorectal cancer and its metastases ', EBioMedicine . https://doi.org/10.1016/j.ebiom.2019.01.050
Background The use of biomarkers to target anti-EGFR treatments for metastatic colorectal cancer (CRC) is well-established, requiring molecular analysis of primary or metastatic biopsies. We aim to review concordance between primary CRC and its metas